These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38061626)

  • 21. Discovery and development of safe-in-man broad-spectrum antiviral agents.
    Andersen PI; Ianevski A; Lysvand H; Vitkauskiene A; Oksenych V; Bjørås M; Telling K; Lutsar I; Dumpis U; Irie Y; Tenson T; Kantele A; Kainov DE
    Int J Infect Dis; 2020 Apr; 93():268-276. PubMed ID: 32081774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
    Nijhuis M; van Maarseveen NM; Boucher CA
    Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safe-in-Man Broad Spectrum Antiviral Agents.
    Yao R; Ianevski A; Kainov D
    Adv Exp Med Biol; 2021; 1322():313-337. PubMed ID: 34258746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silver nanoparticles as potential antiviral agents.
    Galdiero S; Falanga A; Vitiello M; Cantisani M; Marra V; Galdiero M
    Molecules; 2011 Oct; 16(10):8894-918. PubMed ID: 22024958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral Strategies Based on Lethal Mutagenesis and Error Threshold.
    Perales C; Domingo E
    Curr Top Microbiol Immunol; 2016; 392():323-39. PubMed ID: 26294225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA and condensates: Disease implications and therapeutic opportunities.
    Han TW; Portz B; Young RA; Boija A; Klein IA
    Cell Chem Biol; 2024 Sep; 31(9):1593-1609. PubMed ID: 39303698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad-spectrum Respiratory Virus Entry Inhibitors.
    Zhao H; Yuen KY
    Adv Exp Med Biol; 2022; 1366():137-153. PubMed ID: 35412139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plant viruses and biomolecular condensates: novel perspectives in virus replication strategies.
    May JP
    New Phytol; 2024 Sep; 243(5):1636-1638. PubMed ID: 38655603
    [No Abstract]   [Full Text] [Related]  

  • 29. Liquid-liquid Phase Separation in Viral Function.
    Zhang X; Zheng R; Li Z; Ma J
    J Mol Biol; 2023 Aug; 435(16):167955. PubMed ID: 36642156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomolecular condensates: new opportunities for drug discovery and RNA therapeutics.
    Conti BA; Oppikofer M
    Trends Pharmacol Sci; 2022 Oct; 43(10):820-837. PubMed ID: 36028355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulating biomolecular condensates: a novel approach to drug discovery.
    Mitrea DM; Mittasch M; Gomes BF; Klein IA; Murcko MA
    Nat Rev Drug Discov; 2022 Nov; 21(11):841-862. PubMed ID: 35974095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpesvirus Replication Compartments: Dynamic Biomolecular Condensates?
    Caragliano E; Brune W; Bosse JB
    Viruses; 2022 May; 14(5):. PubMed ID: 35632702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics.
    Gutierrez-Chamorro L; Felip E; Ezeonwumelu IJ; Margelí M; Ballana E
    Trends Microbiol; 2021 Sep; 29(9):836-848. PubMed ID: 33618979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of B23/NPM1 in Viral Infections, Potential Uses of B23/NPM1 Inhibitors as Antiviral Therapy.
    Lobaina Y; Perera Y
    Infect Disord Drug Targets; 2019; 19(1):2-16. PubMed ID: 29589547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle.
    Di Nunzio F; Uversky VN; Mouland AJ
    Retrovirology; 2023 Apr; 20(1):4. PubMed ID: 37029379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier.
    Shrestha N; Gall FM; Mathieu C; Hierweger MM; Brügger M; Alves MP; Vesin J; Banfi D; Kalbermatter D; Horvat B; Chambon M; Turcatti G; Fotiadis D; Riedl R; Plattet P
    mBio; 2021 Dec; 12(6):e0262121. PubMed ID: 34724816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge.
    Xu X; Zhang QY; Chu XY; Quan Y; Lv BM; Zhang HY
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834924
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Ahmad G; Sohail M; Bilal M; Rasool N; Qamar MU; Ciurea C; Marceanu LG; Misarca C
    Molecules; 2024 May; 29(10):. PubMed ID: 38792094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
    Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
    Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality.
    Mast FD; Navare AT; van der Sloot AM; Coulombe-Huntington J; Rout MP; Baliga NS; Kaushansky A; Chait BT; Aderem A; Rice CM; Sali A; Tyers M; Aitchison JD
    J Cell Biol; 2020 Oct; 219(10):. PubMed ID: 32785687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.